申请人:Wang Tao
公开号:US20130096305A1
公开(公告)日:2013-04-18
Deuterated piperazine and piperidine HIV attachment inhibitor compounds are set forth. The present invention provides compounds of Formula I, the pharmaceutically acceptable salts and/or solvates (e.g., hydrates) thereof, their pharmaceutical formulations, and their use in patients suffering from or susceptible to a virus such as HIV. The compounds of Formula I, their pharmaceutically acceptable salts and/or solvates are effective antiviral agents, particularly as inhibitors of HIV. They are useful for the treatment of HIV and AIDS.
本发明提供了一种取代了氘代哌嗪和哌啶的HIV附着抑制剂化合物。本发明提供了I式化合物、其药学上可接受的盐和/或溶剂(例如水合物)、它们的制剂以及它们在患有或易感染HIV等病毒的患者中使用。I式化合物及其药学上可接受的盐和/或溶剂是有效的抗病毒剂,特别是HIV抑制剂。它们可用于治疗HIV和AIDS。